(Q35177118)

6 August 2017

1 reference

title

Antiphospholipid antibodies: proposed mechanisms of action (English)

1 reference

6 August 2017

Antiphospholipid Antibodies: Proposed Mechanisms of Action (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

23 November 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

23 November 2023

author name string

D. A. Triplett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285881

9 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1285881

9 September 2022

publication date

1 October 1992

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0897.1992.tb00794.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0897.1992.tb00794.x

23 November 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

American Journal of Reproductive Immunology

23 November 2023

published in

1 reference

6 August 2017

volume

28

1 reference

6 August 2017

issue

3-4

1 reference

6 August 2017

page(s)

211-215

1 reference

The antiphospholipid syndrome. Clinical correlations, cutaneous features, mechanism of thrombosis and treatment of patients with the lupus anticoagulant and anticardiolipin antibodies

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Antiphospholipid antibodies and recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Anticardiolipin antibodies in autoimmune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

The lupus anticoagulant stimulates the release of prostacyclin from human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1992.TB00794.X

Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

The laboratory heterogeneity of lupus anticoagulants

23 November 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Some antiphospholipid antibodies inhibit phospholipase A2 activity

23 November 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

23 November 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Natural antibodies against phospholipids and liposomes in humans

23 November 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Intrauterine death and circulating anticoagulant ("antithromboplastin")

23 November 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

23 November 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

23 November 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels

23 November 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

23 November 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

The protein C anticoagulant pathway

23 November 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production

23 November 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

23 November 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system

23 November 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

23 November 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1600-0897.1992.TB00794.X

23 November 2023

Identifiers

1 reference

6 August 2017

1 reference